Fallout and the Road Ahead
The Express Scripts FTC Changes land at a time of intensifying scrutiny over prescription drug pricing, particularly for insulin, a medication millions of Americans depend on daily.
By stepping away from the legal fray, Express Scripts avoids further litigation while committing to structural adjustments regulators say could recalibrate how drug benefits are priced nationwide.
Whether the promised billions in savings materialize — and whether the remaining cases against other PBMs reshape the broader market — now becomes the next chapter in a battle that has turned complex rebate systems into a national flashpoint.
